Search

ALMIRALL, S.A.

Page 1 out of 11
    • 18/11/2022
    • 07:53
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall perpetually licenses Motilex® to Teofarma in Italy
    • Register number: 19255
    • 10/11/2022
    • 07:58
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall announces that will webcast a conference to introduce and explain the results for the third quarter of 2022
    • Register number: 19138
    • 10/11/2022
    • 07:54
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall files Third Quarter results presentation for 2022
    • Register number: 19137
    • 28/10/2022
    • 07:50
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall announces EMA acceptance for filing of Marketing Authorization Application (MAA) for lebrikizumab in atopic dermatitis
    • Register number: 18925
    • 04/10/2022
    • 09:51
    • ALMIRALL, S.A.
    • Liquidity and counterparty agreements
    • Operaciones del contrato de liquidez durante el tercer trimestre de 2022
    • Register number: 18534
    • 29/09/2022
    • 08:02
    • ALMIRALL, S.A.
    • Other relevant information
    • Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc
    • Register number: 18451
    • 08/09/2022
    • 14:16
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall: Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Phase 3 Monotherapy Atopic Dermatitis Trials
    • Register number: 18149
    • 25/07/2022
    • 07:23
    • ALMIRALL, S.A.
    • On corporate governance
    • Consejo de Administración
    • Register number: 17512
    • 25/07/2022
    • 07:17
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall announces that will webcast a conference to introduce and explain the results for the first half of 2022.
    • Register number: 17511
    • 25/07/2022
    • 07:09
    • ALMIRALL, S.A.
    • On business and financial situation
    • Almirall files First Half results presentation for 2022
    • Register number: 17510
Page 1 out of 11